Differences

This shows you the differences between two versions of the page.

--- covid-19_vaccines:booster_shots [2021/12/29 10:43]
mathew created/imported from removed page
+++ covid-19_vaccines:booster_shots [2022/11/26 12:35] (current)
pamela [Links to Sort]
@@ Line 13: / Line 13: @@
 [[COVID-19 Vaccination Campaigns by Nation]]
+==== RNA for Moderna’s Omicron Booster Manufactured by CIA-Linked Company ====
+Since late last year, messenger RNA for Moderna’s COVID-19 vaccines, including its recently reformulated Omicron booster, has been exclusively manufactured by a little known company with significant ties to US intelligence.
+Unlimited Hangout by Whitney Webb - August 17, 2022
+However, unlike the company’s original COVID-19 vaccine, the genetic material, or messenger RNA (mRNA), for this new vaccine, including the newly formulated genetic material meant to provide protection against the [[:Omicron variant]], is being manufactured, not by Moderna, but by a relatively new company that has received hardly any media attention, despite its overt links to US intelligence. Last September, it was quietly announced that a company called [[:National Resilience]] (often referred to simply as Resilience) would begin manufacturing the mRNA for Moderna [[:COVID-19 vaccine]] products. Under the terms of the multi-year agreement, “Resilience will produce mRNA for the Moderna COVID-19 vaccine at its facility in Mississauga, Ontario, for distribution worldwide.”
+“Reinventing Biomanufacturing”
+National Resilience was founded relatively recently, in November 2020, and describes itself as “a manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.” It has since been building “a sustainable network of high-tech, end-to-end manufacturing solutions with the aim to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale.” It further plans to “reinvent [[:biomanufacturing]]” and “democratize access to medicines,” namely gene therapies, experimental vaccines and other “medicines of tomorrow.”
+In pursuit of those goals, the company announced it would “actively invest in developing powerful new technologies to manufacture complex medicines that are defining the future of therapeutics, including cell and gene therapies, viral vectors, vaccines, and proteins.” It was founded with the reported intention “to build a better system for manufacturing complex medicines to fight deadly diseases” as a way to improve post-COVID “pandemic preparedness.”
+The company initially marketed its manufacturing capabilities as “the Resilience platform”, and  offers principally “RNA Modalities”, including RNA development for [[:vaccines]], [[:gene editing]] and therapeutics; and “Virus Production”, including viral vectors, oncolytic viruses (i.e. a virus engineered to preferentially attack [[:cancer cells]]), viruses for use in vaccine development and gene-edited viruses for unspecified purposes.
+It is worth noting that, to date, many controversial “[[:gain-of-function]]” experiments have justified modifying viruses for the same purposes as described by National Resilience’s Virus Production capabilities. In addition, National Resilience offers product formulations and other modalities, such as biologics and cell therapies, to its clientele and the “Virus Production” of its website has since been removed. ((https://unlimitedhangout.com/2022/08/investigative-reports/rna-for-modernas-omicron-booster-manufactured-by-cia-linked-company/))((https://web.archive.org/web/20220817191733/https://unlimitedhangout.com/2022/08/investigative-reports/rna-for-modernas-omicron-booster-manufactured-by-cia-linked-company/))
 ==== Links to Sort ====